Skip to content

Shares (Diluted) at other companies

Incyte logo
IncyteINCY
206.8M+4.4%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
197.7M+0.6%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
194.8M+2.4%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
45.1M+32.9%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
88.3M+2.4%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
81.3M+33.1%

Other financials

Income statement

See full
Operating income-$42.0M-31.9%
Net income-$39.3M-39.6%
EPS (diluted)-$0.64-36.2%

Balance sheet

See full
Cash & equivalents$85.0M-15.7%
Total debt$5.7M-6.9%
Total equity$387.6M+19.8%
Total assets$412.0M+20.0%

Cash flow

See full
Operating cash flow-$32.6M-27.9%
CapEx$88.0K+529%
Free cash flow-$32.7M-28.2%

Valuation

See full
Market cap$1.81B+318%

Returns & leverage

See full
Return on equity-36.9%+21.1pp
Debt / equity0.0×
Current ratio20.5×-2.3×

Where this comes from

Reported directly by Tyra Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tyra Biosciences, Inc.'s shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tyra Biosciences, Inc.'s shares (diluted)?
Tyra Biosciences, Inc. (TYRA) reported shares (diluted) of 61.7M in Q1 2026.
How has Tyra Biosciences, Inc.'s shares (diluted) changed year-over-year?
Tyra Biosciences, Inc.'s shares (diluted) increased by 4.1% year-over-year, from 59.3M to 61.7M.
What is the long-term trend for Tyra Biosciences, Inc.'s shares (diluted)?
Over 4 years (2021 to 2025), Tyra Biosciences, Inc.'s shares (diluted) has grown at a 72.0% compound annual growth rate (CAGR), from 27.2M to 238.2M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.